AT-Patch (ATP-C130/ATP-C70) vs LVivo IQS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AT-Patch (ATP-C130/ATP-C70)
by ATsens Co.
VS
LVivo IQS
by DiA Imaging Analysis

AI Verdict

These tools are adjacent within the cardiology AI space, as they apply AI to different diagnostic modalities. AT-Patch is designed for continuous ECG monitoring to detect arrhythmias, whereas LVivo IQS enhances the analysis of cardiac ultrasound images for structural and functional assessment. Therefore, they serve distinct clinical purposes.

Choose AT-Patch (ATP-C130/ATP-C70) if…

Choose AT-Patch if you require extended, continuous ambulatory ECG monitoring for arrhythmia detection, especially when patient comfort and water resistance are important factors. Its 14-day monitoring capability and integrated AI-powered analysis are ideal for identifying intermittent cardiac events that might be missed by shorter monitoring periods.

View AT-Patch (ATP-C130/ATP-C70) →

Choose LVivo IQS if…

Choose LVivo IQS if your primary need is to automate and standardize the analysis of ultrasound images, particularly for cardiac function assessment. This tool is best suited for improving diagnostic confidence and efficiency by providing AI-powered real-time image quality feedback and objective measurements of ventricular function, either at the bedside or retrospectively on PACS.

View LVivo IQS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AT-Patch (ATP-C130/ATP-C70) LVivo IQS
Pricing N/a Contact for pricing
Deployment Wearable device for patients; analysis software deployed on-premise at medical institutions. On ultrasound devices (near bedside) and off-line on healthcare IT PACS systems/servers.
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AT-Patch (ATP-C130/ATP-C70)

AT-Patch prioritizes patient comfort and ease of use for extended monitoring, featuring a compact, lightweight, and shower-proof design that requires no charging or electrode replacement during the monitoring period. This focus on patient-centric design, alongside clinician analysis software, gives it a broader scope of usability across the care continuum.

Clinical Value

LVivo IQS

LVivo IQS offers significant clinical value by standardizing and automating complex, operator-dependent ultrasound measurements, directly addressing variability and enhancing diagnostic confidence with objective data. While AT-Patch provides valuable extended ECG monitoring, LVivo IQS's impact on the consistency and accuracy of critical cardiac imaging interpretation is arguably more profound for diagnostic decision-making.

Pricing & Value

Tie

Neither AT-Patch nor LVivo IQS provides publicly available pricing information, both requiring direct contact for details. Without transparent pricing, it is impossible to conduct a head-to-head comparison on cost or objectively assess which tool offers better value for money.

Enterprise Readiness

LVivo IQS

LVivo IQS explicitly highlights its vendor-neutral software solution and deployment on existing ultrasound devices and PACS systems, indicating robust integration capabilities within diverse hospital IT environments. While AT-Patch's on-premise software also suggests enterprise deployment, LVivo IQS's stated compatibility offers a clearer advantage for seamless enterprise integration.

Innovation

LVivo IQS

LVivo IQS demonstrates higher innovation by applying AI to provide real-time image quality feedback and automate complex analysis directly within the dynamic ultrasound scanning process. This pushes the boundaries of AI assistance in live diagnostic procedures more significantly than AT-Patch's wearable design and post-collection analysis.

Support & Docs

Tie

The provided information and general web searches do not offer sufficient specific details on the support structures, training programs, or documentation available for either AT-Patch or LVivo IQS. Therefore, a meaningful comparison on this dimension is not possible.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AT-Patch (ATP-C130/ATP-C70) LVivo IQS
Product Type Wearable ECG monitor and analysis software AI-powered ultrasound analysis software
Company ATsens Co. DiA Imaging Analysis
Key Functionality Continuous ECG monitoring (up to 14 days), AI-powered arrhythmia detection, live ECG viewing via smartphone app, symptom recording. AI-powered real-time image quality feedback for ultrasound, automated analysis of ultrasound images, global and segmental left/right ventricle function evaluation.
Specialties Cardiology, Family Medicine, Internal Medicine Cardiology, Emergency Medicine, Radiology

Videos

Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and LVivo IQS.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AT-Patch is an FDA-cleared wearable ECG monitor designed for continuous cardiac monitoring for up to 14 days, primarily focused on arrhythmia detection. LVivo IQS, also FDA-cleared, is an AI-powered ultrasound solution that automates and enhances image analysis for evaluating cardiac function, such as global and segmental left ventricle (LV) and right ventricular (RV) function.
AT-Patch is a wearable device for patients, with its AI-powered analysis software deployed on-premise at medical institutions. LVivo IQS is deployed directly on ultrasound devices, potentially near the bedside, and can also be utilized off-line on healthcare IT PACS systems or servers for image interpretation.
AT-Patch provides continuous ECG monitoring with AI/machine learning algorithms for enhanced arrhythmia detection and rhythm analysis. LVivo IQS offers automated analysis of ultrasound images, including global and segmental left ventricle (LV) function evaluation (ejection fraction, strain, wall motion) and right ventricular (RV) function evaluation.
AT-Patch uses AI/machine learning algorithms within its AT-Report software for ECG analysis to enhance arrhythmia detection. LVivo IQS employs AI to provide real-time image quality feedback during ultrasound scanning and to automate the analysis of ultrasound images, aiming to reduce variability and increase efficiency in interpretation.
AT-Patch is a compact and lightweight (13g) wearable device that patients wear for continuous ECG monitoring for up to 14 days, with a shower-proof design and no need for charging or electrode replacement during monitoring. LVivo IQS is a software solution that analyzes ultrasound images, meaning patient interaction is primarily with the ultrasound procedure itself rather than directly with the software.
Both AT-Patch and LVivo IQS are FDA-cleared. AT-Patch is likely HIPAA compliant given its operation within the US healthcare system for patient data, though a Business Associate Agreement (BAA) is not explicitly mentioned. LVivo IQS is explicitly HIPAA compliant and implies a BAA due to its handling of Protected Health Information (PHI).

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring AT-Patch (ATP-C130/ATP-C70) or LVivo IQS

Backers

Who funded each tool's parent company.

LVivo IQS

AI Tool Finder
AI-powered search. Results may not be comprehensive.